Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 17c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.39), $0.17 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $250 thousand versus the consensus estimate of $2.5 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker
• Walmart (WMT) call put ratio 1.2 calls to 1 put into quarter results
• 374Water Inc (SCWO) Misses Q2 EPS by 15c